COLLABORATE El Meu Clínic .This link opens in a new tab.
COLLABORATE El Meu Clínic .This link opens in a new tab.
Navigation thread
Navigation thread
Applied research in infectious respiratory diseases and critically ill patients

Featured projects

  • Combined Effectiveness of Antibiotics and Bacteriophages for Personalised Treatment of Ventilator-Associated Pneumonia Caused by Pseudomonas aeruginosa

    Principal investigator: Laia Fernández Barat.
    Funder: Fundació La Marató de TV3.
    Duration: 01/01/2026 - 31/12/2028

  • PREDICT-SARC: Identificació precoç del fracàs terapèutic en la sarcoïdosi pulmonar mitjançant una anàlisi multiòmica integrada

    Principal investigator: Jacobo Sellarés Torres.
    Funder: Fundació La Marató de TV3.
    Code: 202534-30-31-32-33.
    Duration: 01/01/2026

  • SARCOIDOMICS: Advancing in High-Risk Sarcoidosis Research Through Multi-Omics

    Principal investigator: Jacobo Sellarés Torres.
    Funder: European Respiratory Society.
    Duration: 01/04/2025

  • HOMI-LUNG: Long-term alterations of host-microbiome interactions and cardiovascular and respiratory diseases progression after pneumonia

    Principal investigator: Laia Fernández Barat, Antoni Torres Marti.
    Funder: European Commission.
    Code: 101137148.
    Duration: 01/01/2024 - 31/12/2028

  • PHAGE-VAP: Engineered phages for the treatment of ventilator-associated pneumonia

    Principal investigator: Laia Fernández Barat.
    Funder: Centro de Investigación Biomédica en Red.
    Duration: 01/01/2024 - 31/12/2027

  • PIRAMYD: Interacción entre factores de riesgo, complicaciones, secuelas y base biológica en insuficiencia respiratoria aguda

    Principal investigator: Miquel Ferrer Monreal.
    Funder: Ministerio de Ciencia e Innovación.
    Code: PID2022-141924OB-I00.
    Duration: 01/01/2023 - 31/12/2026

  • FIBROPROG: Identificando nuevos biomarcadores de fibrosis pulmonar progresiva, avanzando hacia la medicina de precisión

    Principal investigator: Jacobo Sellarés Torres.
    Funder: Instituto de Salud Carlos III.
    Code: PI23/00924.
    Duration: 01/01/2023 - 31/12/2026

  • HAP2: Host-targeted Approaches for the Prevention and the treatment of Hospital-Acquired Pneumonia

    Principal investigator: Antoni Torres Marti.
    Funder: European Commission.
    Code: 847782.
    Duration: 01/01/2020 - 31/12/2026

  • ProCIBERdexa: Proyecto multidisciplinar CIBER para optimizar la dosis de dexametasona en pacientes con insuficiencia respiratoria

    Principal investigator: Carlos Ferrando Ortolá.
    Funder: Centro de Investigacion Biomedica en Red de Enfermedades Respiratorias.
    Code: ICI20/00062.
    Duration: 01/01/2020 - 31/12/2026

Major founders

The research of this group can be carried out thanks to the funders.